BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li SY, Li JS, Wang MH, Xie Y, Yu XQ, Sun ZK, Ma LJ, Zhang W, Zhang HL, Cao F, Pan YC. Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study. BMC Complement Altern Med 2012;12:197. [PMID: 23107470 DOI: 10.1186/1472-6882-12-197] [Cited by in Crossref: 61] [Cited by in F6Publishing: 69] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Zu Y, Li D, Lei X, Zhang H. Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: study protocol of a randomized, double-blind, placebo-controlled trial. Trials 2019;20:647. [PMID: 31775843 DOI: 10.1186/s13063-019-3729-1] [Reference Citation Analysis]
2 Kong Q, Mo S, Wang W, Tang Z, Wei Y, Du Y, Liu B, Kong L, Lv Y, Dong J. Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial. Trials 2020;21:760. [PMID: 32883322 DOI: 10.1186/s13063-020-04669-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cho WC, Lee MS, Lao L, Litscher G. Systematic review and meta-analysis in chinese medicine. Evid Based Complement Alternat Med 2014;2014:859309. [PMID: 25243013 DOI: 10.1155/2014/859309] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
4 Li J, Zhao P, Tian Y, Li K, Zhang L, Guan Q, Mei X, Qin Y. The Anti-Inflammatory Effect of a Combination of Five Compounds From Five Chinese Herbal Medicines Used in the Treatment of COPD. Front Pharmacol 2021;12:709702. [PMID: 34776947 DOI: 10.3389/fphar.2021.709702] [Reference Citation Analysis]
5 Liu W, Yang S, Fu M, Li J, Song Y, Wei B, Liu E, Sun Z. Chinese patent medicine for chronic obstructive pulmonary disease based on principles of tonifying Qi, promoting blood circulation by removing blood stasis, and resolving phlegm: a systematic review of randomized controlled trials. J Tradit Chin Med 2015;35:1-10. [PMID: 25842721 DOI: 10.1016/s0254-6272(15)30001-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang CY, Ding HZ, Tang X, Li ZG. Effect of Liuweibuqi capsules on CD4+CD25+Foxp3+ regulatory T cells, helper T cells and lung function in patients with stable chronic obstructive pulmonary disease complicated with lung Qi deficiency. J Thorac Dis 2018;10:2700-11. [PMID: 29997932 DOI: 10.21037/jtd.2018.04.110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Chen Y, Lin L, Wu L, Xu Y, Shergis JL, Zhang AL, Wen Z, Worsnop C, Da Costa C, Thien F, Xue CC. Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial. Int J Chron Obstruct Pulmon Dis 2020;15:671-80. [PMID: 32273696 DOI: 10.2147/COPD.S236425] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Tian Y, Li Y, Li J, Feng S, Li S, Mao J, Xie Y, Liu X, Dong H, Zheng W, Wang M. Bufei Yishen Granules Combined with Acupoint Sticking Therapy Suppress Inflammation in Chronic Obstructive Pulmonary Disease Rats: Via JNK/p38 Signaling Pathway. Evid Based Complement Alternat Med 2017;2017:1768243. [PMID: 29234369 DOI: 10.1155/2017/1768243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
9 Li J, Yang L, Yao Q, Li Y, Tian Y, Li S, Jiang S, Wang Y, Li X, Guo Z. Effects and mechanism of bufei yishen formula in a rat chronic obstructive pulmonary disease model. Evid Based Complement Alternat Med 2014;2014:381976. [PMID: 24959185 DOI: 10.1155/2014/381976] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
10 Li J, Zhao P, Li Y, Tian Y, Wang Y. Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease. Sci Rep 2015;5:15290. [PMID: 26469778 DOI: 10.1038/srep15290] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 9.1] [Reference Citation Analysis]
11 Li Y, Tian Y, Li J, Dong Y, Wang M, Feng S, Li L, Mao J, Wang L, Luo S. Bufei Yishen granules combined with acupoint sticking therapy suppress oxidative stress in chronic obstructive pulmonary disease rats: Via regulating peroxisome proliferator-activated receptor-gamma signaling. Journal of Ethnopharmacology 2016;193:354-61. [DOI: 10.1016/j.jep.2016.08.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
12 Wang Y, Jiang Y, Ge J, Zhang Z, Dong J. Effects of Jianpi Yiqi method for chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20566. [PMID: 32541482 DOI: 10.1097/MD.0000000000020566] [Reference Citation Analysis]
13 Chen HY, Ma CH, Cao KJ, Chung-Man Ho J, Ziea E, Wong VT, Zhang ZJ. A systematic review and meta-analysis of herbal medicine on chronic obstructive pulmonary diseases. Evid Based Complement Alternat Med 2014;2014:925069. [PMID: 24795773 DOI: 10.1155/2014/925069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
14 Wang Z, Yang W, Yang P, Gao B, Luo L. Effect of Radix Stemonae concentrated decoction on the lung tissue pathology and inflammatory mediators in COPD rats. BMC Complement Altern Med 2016;16:457. [PMID: 27832794 DOI: 10.1186/s12906-016-1444-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Li J, Xie Y, Zhao P, Qin Y, Oliver BG, Tian Y, Li S, Wang M, Liu X. A chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38. Phytomedicine 2021;83:153475. [PMID: 33545548 DOI: 10.1016/j.phymed.2021.153475] [Reference Citation Analysis]
16 Li JS, Xie Y, Li SY, Yu XQ. Comparison of conventional medicine, TCM treatment, and combination of both conventional medicine and TCM treatment for patients with chronic obstructive pulmonary disease: study protocol of a randomized comparative effectiveness research trial. Trials 2014;15:153. [PMID: 24885672 DOI: 10.1186/1745-6215-15-153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Barbetta C, Currow DC, Johnson MJ. Non-opioid medications for the relief of chronic breathlessness: current evidence. Expert Rev Respir Med 2017;11:333-41. [PMID: 28282499 DOI: 10.1080/17476348.2017.1305896] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
18 Coyle M, Shergis JL, Liu S, Wu L, Zhang AL, Guo X, Lu C, Xue CC. Safety of chinese herbal medicine for chronic obstructive pulmonary disease. Evid Based Complement Alternat Med 2015;2015:380678. [PMID: 25883670 DOI: 10.1155/2015/380678] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
19 Fan Y, Wen X, Zhang Q, Wang F, Li Q, Li X, Guo Y. Effect of Traditional Chinese Medicine Bufei Granule on Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis Based on Existing Evidence. Evid Based Complement Alternat Med 2020;2020:3439457. [PMID: 32089718 DOI: 10.1155/2020/3439457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Zhao P, Yang L, Li J, Li Y, Tian Y, Li S. Combining systems pharmacology, transcriptomics, proteomics, and metabolomics to dissect the therapeutic mechanism of Chinese herbal Bufei Jianpi formula for application to COPD. Int J Chron Obstruct Pulmon Dis 2016;11:553-66. [PMID: 27042044 DOI: 10.2147/COPD.S100352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Zhao P, Li J, Yang L, Li Y, Tian Y, Li S. Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease. Mol Med Rep 2018;17:5247-57. [PMID: 29393428 DOI: 10.3892/mmr.2018.8480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Chen X, May B, Di YM, Zhang AL, Lu C, Xue CC, Lin L. Oral Chinese herbal medicine combined with pharmacotherapy for stable COPD: a systematic review of effect on BODE index and six minute walk test. PLoS One 2014;9:e91830. [PMID: 24622390 DOI: 10.1371/journal.pone.0091830] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
23 Yange T, Ya L, Jiansheng L, Suyun L, Suli J, Ying W, Xiaofan L, Weiwei L. Effects of therapies for regulating and reinforcing lung and kidney on osteoporosis in rats with chronic obstructive pulmonary disease. J Tradit Chin Med 2015;35:175-83. [PMID: 25975050 DOI: 10.1016/s0254-6272(15)30025-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
24 Lu X, Li Y, Li J, Wang H, Wu Z, Li H, Wang Y. Sequential Treatments with Tongsai and Bufei Yishen Granules Reduce Inflammation and Improve Pulmonary Function in Acute Exacerbation-Risk Window of Chronic Obstructive Pulmonary Disease in Rats. Evid Based Complement Alternat Med 2016;2016:1359105. [PMID: 27563333 DOI: 10.1155/2016/1359105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Dong Y, Li Y, Sun Y, Mao J, Yao F, Tian Y, Wang L, Li L, Li S, Li J. Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease. BMC Complement Altern Med 2015;15:51. [PMID: 25888379 DOI: 10.1186/s12906-015-0559-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
26 Mao J, Li Y, Li S, Li J, Tian Y, Feng S, Liu X, Bian Q, Li J, Hu Y, Zhang L, Ji H. Bufei Jianpi Granules Reduce Quadriceps Muscular Cell Apoptosis by Improving Mitochondrial Function in Rats with Chronic Obstructive Pulmonary Disease. Evid Based Complement Alternat Med 2019;2019:1216305. [PMID: 30723509 DOI: 10.1155/2019/1216305] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
27 Shen DD, Yang ZH, Huang J, Yang F, Lin ZW, Ou YF, Hu MH. Liuweibuqi capsules improve pulmonary function in stable chronic obstructive pulmonary disease with lung-qi deficiency syndrome by regulating STAT4/STAT6 and MMP-9/TIMP-1. Pharm Biol 2019;57:744-52. [PMID: 31679431 DOI: 10.1080/13880209.2019.1666151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Zhao P, Li J, Li Y, Tian Y, Wang Y, Zheng C. Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD. Int J Chron Obstruct Pulmon Dis 2015;10:2633-56. [PMID: 26674991 DOI: 10.2147/COPD.S94043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
29 Chen Y, Wang QW, Zuo J, Chen JW, Li X. Anti-arthritic activity of ethanol extract of Claoxylon indicum on Freund's complete adjuvant-induced arthritis in mice. BMC Complement Altern Med 2017;17:11. [PMID: 28056924 DOI: 10.1186/s12906-016-1500-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
30 Yu XQ, Yang SG, Li H, Xie Y, Li JS, Zhang P. Preliminary Study to Evaluate Three Different Treatments on Stable Chronic Obstructive Pulmonary Disease Patients Based on Markov Model. Evid Based Complement Alternat Med 2019;2019:6478926. [PMID: 31118965 DOI: 10.1155/2019/6478926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Zhou P, Yu W, Zhang C, Chen K, Tang W, Li X, Liu Z, Xia Q. Tiao-bu-fei-shen formula promotes downregulation of the caveolin 1-p38 mapk signaling pathway in COPD - Associated tracheobronchomalacia cell model. J Ethnopharmacol 2022;293:115256. [PMID: 35367574 DOI: 10.1016/j.jep.2022.115256] [Reference Citation Analysis]
32 Luo J, Zhang Y, Hu X, Zhong S, Chen G, Wang Y, Lin W, Yi C, Zhu H. The effects of modified sini decoction on liver injury and regeneration in acute liver failure induced by D-galactosamine in rats. J Ethnopharmacol 2015;161:53-9. [PMID: 25499312 DOI: 10.1016/j.jep.2014.12.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
33 Liu M, Wu K, Lin J, Xie Q, Liu Y, Huang Y, Zeng J, Yang Z, Wang Y, Dong S, Deng W, Yang M, Wu S, Jiang W, Li X. Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease? Front Pharmacol 2021;12:695957. [PMID: 34305606 DOI: 10.3389/fphar.2021.695957] [Reference Citation Analysis]
34 Wang M, Li J, Li S, Xie Y. Effects of comprehensive therapy based on traditional Chinese medicine patterns on older patients with chronic obstructive pulmonary disease: a subgroup analysis from a four-center, randomized, controlled study. Front Med 2014;8:368-75. [DOI: 10.1007/s11684-014-0360-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
35 Tian Y, Li Y, Li J, Xie Y, Wang M, Dong Y, Li L, Mao J, Wang L, Luo S. Bufei Yishen granule combined with acupoint sticking improves pulmonary function and morphormetry in chronic obstructive pulmonary disease rats. BMC Complement Altern Med 2015;15:266. [PMID: 26253241 DOI: 10.1186/s12906-015-0787-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
36 Zhao P, Liu X, Dong H, Tian Y, Feng S, Zhao D, Ren Z, Zhang L, Li J. Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor. Front Pharmacol 2020;11:1212. [PMID: 32848801 DOI: 10.3389/fphar.2020.01212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Haifeng W, Hailong Z, Jiansheng L, Xueqing Y, Suyun L, Bin L, Yang X, Yunping B. Effectiveness and safety of traditional Chinese medicine on stable chronic obstructive pulmonary disease: A systematic review and meta-analysis. Complementary Therapies in Medicine 2015;23:603-11. [DOI: 10.1016/j.ctim.2015.06.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
38 Liu Y, Zeng S, Li Y, Zhuang G, Su Y, Liu X, Chen L, Feng Q. The effect of acupoint application of traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22730. [PMID: 33120771 DOI: 10.1097/MD.0000000000022730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Wang G, Liu B, Cao Y, Du Y, Zhang H, Luo Q, Li B, Wu J, Lv Y, Sun J, Jin H, Wei K, Zhao Z, Kong L, Zhou X, Miao Q, Wang G, Zhou Q, Dong J. Effects of two Chinese herbal formulae for the treatment of moderate to severe stable chronic obstructive pulmonary disease: a multicenter, double-blind, randomized controlled trial. PLoS One 2014;9:e103168. [PMID: 25118962 DOI: 10.1371/journal.pone.0103168] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
40 Li Y, Li JS, Li WW, Li SY, Tian YG, Lu XF, Jiang SL, Wang Y. Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease. BMC Complement Altern Med 2014;14:140. [PMID: 24766819 DOI: 10.1186/1472-6882-14-140] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
41 Chen Y, Shergis JL, Wu L, Yu X, Zeng Q, Xu Y, Guo X, Zhang AL, Xue CC, Lin L. A systematic review and meta-analysis of the herbal formula Buzhong Yiqi Tang for stable chronic obstructive pulmonary disease. Complementary Therapies in Medicine 2016;29:94-108. [DOI: 10.1016/j.ctim.2016.09.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
42 Zhao P, Li J, Tian Y, Mao J, Liu X, Feng S, Li J, Bian Q, Ji H, Zhang L. Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula. Journal of Ethnopharmacology 2018;217:152-62. [DOI: 10.1016/j.jep.2018.02.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
43 Yu XQ, Wang MH, Li JS, Li SY, Xie Y, Bai YP, Zhang HL, Cao F, Hou CX, Ma LJ. Effect of Comprehensive Therapy based on Chinese Medicine Patterns on Self-Efficacy and Effectiveness Satisfaction in Chronic Obstructive Pulmonary Disease Patients. Chin J Integr Med 2019;25:736-42. [PMID: 28887809 DOI: 10.1007/s11655-017-2417-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
44 Ma J, Tian Y, Li J, Zhang L, Wu M, Zhu L, Liu S. Effect of Bufei Yishen Granules Combined with Electroacupuncture in Rats with Chronic Obstructive Pulmonary Disease via the Regulation of TLR-4/NF-κB Signaling. Evid Based Complement Alternat Med 2019;2019:6708645. [PMID: 31275415 DOI: 10.1155/2019/6708645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
45 Li J, Wang J, Li Y, Zhao P, Tian Y, Liu X, He H, Jia R. Effective-component compatibility of Bufei Yishen formula protects COPD rats against PM2.5-induced oxidative stress via miR-155/FOXO3a pathway. Ecotoxicol Environ Saf 2021;228:112918. [PMID: 34773846 DOI: 10.1016/j.ecoenv.2021.112918] [Reference Citation Analysis]
46 Liu Z, Huang Y, Cui Z, Tan Y, Yang J, Lü A, Wang Y, Jiang M. Application of Traditional Chinese Medicine in medical practice: a survey of community residents in Beijing, China. J Tradit Chin Med 2017;37:261-8. [PMID: 29961274 DOI: 10.1016/s0254-6272(17)30053-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
47 Jin F, Zhang L, Chen K, Miao Y, Liu Y, Tian Y, Li J, Carbone F. Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-κB Signaling. BioMed Research International 2022;2022:1-13. [DOI: 10.1155/2022/3360771] [Reference Citation Analysis]
48 Li J, Zhao P, Yang L, Li Y, Tian Y, Li S. System biology analysis of long-term effect and mechanism of Bufei Yishen on COPD revealed by system pharmacology and 3-omics profiling. Sci Rep 2016;6:25492. [PMID: 27146975 DOI: 10.1038/srep25492] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
49 Luo J, Zhang Y, Hu X, Chen G, Liu X, Nie H, Liu J, Wen D. Aqueous extract from Aconitum carmichaelii Debeaux reduces liver injury in rats via regulation of HMGB1/TLR4/NF-ΚB/caspase-3 and PCNA signaling pathways. Journal of Ethnopharmacology 2016;183:187-92. [DOI: 10.1016/j.jep.2016.01.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
50 Li J, Ma J, Tian Y, Zhao P, Liu X, Dong H, Zheng W, Feng S, Zhang L, Wu M, Zhu L, Liu S, Zhao D. Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling. J Ethnopharmacol 2020;257:112796. [PMID: 32344236 DOI: 10.1016/j.jep.2020.112796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
51 Qian CL, Fan R. Effect of Pingchuan Guben decoction on patients with chronic obstructive pulmonary disease: Results from a randomized comparative effectiveness research trial. Exp Ther Med 2017;14:3915-25. [PMID: 29043001 DOI: 10.3892/etm.2017.5018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Liu L, Qin Y, Cai Z, Tian Y, Liu X, Li J, Zhao P. Effective-components combination improves airway remodeling in COPD rats by suppressing M2 macrophage polarization via the inhibition of mTORC2 activity. Phytomedicine 2021;92:153759. [PMID: 34600177 DOI: 10.1016/j.phymed.2021.153759] [Reference Citation Analysis]
53 Clarke R, Lundy FT, Mcgarvey L. Herbal treatment in asthma and COPD – current evidence. Clin Phytosci 2015;1. [DOI: 10.1186/s40816-015-0005-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
54 Shergis JL, Liu S, Chen X, Zhang AL, Guo X, Lu C, Xue CC. Dang Shen [ Codonopsis pilosula (Franch.) Nannf] Herbal Formulae for Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis: A REVIEW OF DANG SHEN HERBAL FORMULAE FOR COPD. Phytother Res 2015;29:167-86. [DOI: 10.1002/ptr.5248] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
55 Li X, Li Y, Mao J, Bian Q, Xuan Y, Shen T, Li S. Combination of Chinese and Western Medicine Optimizes the Intestinal Microbiota of Exacerbated Chronic Obstructive Pulmonary Disease in Rats. Evid Based Complement Alternat Med 2021;2021:9975407. [PMID: 34539809 DOI: 10.1155/2021/9975407] [Reference Citation Analysis]
56 Hu Y, Shi Q, Ying S, Zhu D, Chen H, Yang X, Xu J, Xu F, Tao F, Xu B. Effects of compound Caoshi silkworm granules on stable COPD patients and their relationship with gut microbiota: A randomized controlled trial. Medicine (Baltimore) 2020;99:e20511. [PMID: 32481473 DOI: 10.1097/MD.0000000000020511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
57 Li J, Li S, Xie Y, Yu X, Wang M, Sun Z, Ma L, Jia X, Zhang H, Xu J, Hou C. The effective evaluation on symptoms and quality of life of chronic obstructive pulmonary disease patients treated by comprehensive therapy based on traditional Chinese medicine patterns. Complementary Therapies in Medicine 2013;21:595-602. [DOI: 10.1016/j.ctim.2013.09.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
58 Zeng S, Liu Y, Wang X, Zhang L, Guo Y, Feng Q. Traditional Chinese Medicine Could Play an Important Role in Integrative Palliative Care in China. J Altern Complement Med 2020;26:770-3. [PMID: 32924559 DOI: 10.1089/acm.2020.0160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Liu A, Wu J, Li A, Bi W, Liu T, Cao L, Liu Y, Dong L. The inhibitory mechanism of Cordyceps sinensis on cigarette smoke extract-induced senescence in human bronchial epithelial cells. Int J Chron Obstruct Pulmon Dis 2016;11:1721-31. [PMID: 27555762 DOI: 10.2147/COPD.S107396] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
60 Li JS, Liu XF, Dong HR, Zheng WC, Feng SX, Tian YG, Zhao P, Ma JD, Ren ZX, Xie Y. Effective-constituent compatibility-based analysis of Bufei Yishen formula, a traditional herbal compound as an effective treatment for chronic obstructive pulmonary disease. J Integr Med 2020;18:351-62. [PMID: 32565294 DOI: 10.1016/j.joim.2020.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Tian Y, Li J, Li Y, Dong Y, Yao F, Mao J, Li L, Wang L, Luo S, Wang M. Effects of Bufei Yishen Granules Combined with Acupoint Sticking Therapy on Pulmonary Surfactant Proteins in Chronic Obstructive Pulmonary Disease Rats. Biomed Res Int 2016;2016:8786235. [PMID: 27699176 DOI: 10.1155/2016/8786235] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
62 Hu WP, Wu XD, Li ZZ, Zhang J. Preventive Effects of Qingfei Yihuo Capsules () on Air Pollution Associated Exacerbation of Chronic Obstructive Pulmonary Disease: A Single-blind, Randomized, Controlled Trial. Chin J Integr Med 2020;26:806-11. [PMID: 32876858 DOI: 10.1007/s11655-020-3321-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Ma J, Zheng J, Zhong N, Bai C, Wang H, Du J, Li F, Chen Y, Shi Z, Li X, Chen P. Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study. Int J Chron Obstruct Pulmon Dis 2018;13:3107-14. [PMID: 30323581 DOI: 10.2147/COPD.S170555] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
64 Li M, Li Y, Li J, Zhao P, Bai Y, Feng S, Liu X, Wang Y, Bian Q, Li J. Long-Term Effects of TCM Yangqing Kangxian Formula on Bleomycin-Induced Pulmonary Fibrosis in Rats via Regulating Nuclear Factor-κB Signaling. Evid Based Complement Alternat Med 2017;2017:2089027. [PMID: 29387126 DOI: 10.1155/2017/2089027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
65 Zhang XW, Liu W, Jiang HL, Mao B. Dissection of Pharmacological Mechanism of Chinese Herbal Medicine Yihuo Huatan Formula on Chronic Obstructive Pulmonary Disease: A Systems Pharmacology-Based Study. Sci Rep 2019;9:13431. [PMID: 31530860 DOI: 10.1038/s41598-019-50064-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
66 Zhao P, Li J, Li Y, Tian Y, Yang L, Li S. Integrating Transcriptomics, Proteomics, and Metabolomics Profiling with System Pharmacology for the Delineation of Long-Term Therapeutic Mechanisms of Bufei Jianpi Formula in Treating COPD. Biomed Res Int 2017;2017:7091087. [PMID: 28424787 DOI: 10.1155/2017/7091087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
67 Di MY, Tang JL. Adaption and application of the four phase trials to traditional chinese medicines. Evid Based Complement Alternat Med 2013;2013:128030. [PMID: 24027591 DOI: 10.1155/2013/128030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
68 Mao J, Li Y, Feng S, Liu X, Tian Y, Bian Q, Li J, Hu Y, Zhang L, Ji H, Li S. Bufei Jianpi Formula Improves Mitochondrial Function and Suppresses Mitophagy in Skeletal Muscle via the Adenosine Monophosphate-Activated Protein Kinase Pathway in Chronic Obstructive Pulmonary Disease. Front Pharmacol 2020;11:587176. [PMID: 33390958 DOI: 10.3389/fphar.2020.587176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Santana FP, Pinheiro NM, Mernak MI, Righetti RF, Martins MA, Lago JH, Lopes FD, Tibério IF, Prado CM. Evidences of Herbal Medicine-Derived Natural Products Effects in Inflammatory Lung Diseases. Mediators Inflamm 2016;2016:2348968. [PMID: 27445433 DOI: 10.1155/2016/2348968] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]